ArticleFrontiers in medicine2025
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Giant Cell Tumor of the Sacrum: A Narrative Review of Management Challenges and Modalities.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary malignant giant cell tumor of bone (PMGCTB), which is usually confirmed to contain a high-grade sarcomatous component at the time of initial diagnosis, accounts for 1.6% of giant cell tumors of bone (GCTB). PMGCTB usually occurs in the epiphysis of long bones, which is similar to GCTB, and only 1.4-9.4% of GCTB occurs in the spine. PMGCTB in the spine is extremely rare. Herein, we present the case of a 46-year-old man who came to the hospital seeking medical help for lumbosacral pain. Computed tomography (CT) was performed because the clinician suspected that the patient had a herniated disk, and the results showed that the fifth lumbar vertebrae to the second sacral vertebrae showed bone destruction, accompanied by soft tissue tumors near the vertebrae, some of which protruded into the spinal canal and sacral canal. Magnetic resonance imaging (MRI) revealed that the lesion demonstrates an isointense signal on T1-weighted imaging (T1WI), a mixed hyperintense signal on T2-weighted imaging (T2WI), and obvious enhancement on contrast-enhanced T1WI. Fluorine-18 fluorodeoxyglucose (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.